Mayflower Bioscience

Mayflower Bioscience

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Mayflower Bioscience is a privately held, revenue-generating distributor founded in 2016, specializing in high-value research reagents, kits, and instruments for the life science sector. Its core business model is built on identifying and securing North American distribution rights for novel technologies developed primarily by European and other international companies. The company serves academic, biotech, and pharmaceutical researchers, with a product portfolio spanning oncology, infectious disease, and general cell and molecular biology applications. Its strategic value lies in its curated network of innovative suppliers and its US-based technical and customer support.

OncologyInfectious Disease

Technology Platform

A distribution and market access platform that sources, commercializes, and provides technical support for innovative life science research tools from global suppliers to the North American market.

Opportunities

Capitalizing on the strong demand for novel research tools in high-growth fields like oncology and infectious disease.
Expanding its portfolio by partnering with more emerging international biotech innovators seeking North American market access.

Risk Factors

High dependency on third-party supplier agreements and product performance.
Intense competition from large, established life science distributors with greater resources and broader catalogs.

Competitive Landscape

Operates in a niche segment of the life science distribution market, competing against giants like Thermo Fisher and Merck by offering curated, unique products from smaller international companies. Its differentiator is specialized market access and US-based support for these novel tools.